Immune Thrombocytopenia Induced by Sintilimab in Lung Cancer:
A Case Report and Literature Review / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 717-720, 2023.
Article
in Zh
| WPRIM
| ID: wpr-1010079
Responsible library:
WPRO
ABSTRACT
Immune checkpoint inhibitors (ICIs) show unique advantages in the treatment of lung cancer, making the treatment of lung cancer enter the era of immunotherapy, but ICIs will also have adverse reactions, and the incidence of immune-induced hematological toxicity is not very high. Immunotherapy-induced thrombocytopenia is a rare adverse event.We report one case of thrombocytopenia induced by ICIs and review the literature on thrombocytopenia associated with ICIs and discuss the clinical features, possible mechanisms, and optimal treatment.
.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Thrombocytopenia
/
Purpura, Thrombocytopenic, Idiopathic
/
Antibodies, Monoclonal, Humanized
/
Lung Neoplasms
Limits:
Humans
Language:
Zh
Journal:
Chinese Journal of Lung Cancer
Year:
2023
Type:
Article